文献速递临床试验与 GCP医学人工智能与信息学

支持越南青少年服药依从性(SAAV)研究:评估移动健康干预改善越南HIV感染青少年服药依从性的随机对照试验研究方案

The Supporting Adolescent Adherence in Vietnam (SAAV) study: study protocol for a randomized controlled trial assessing an mHealth approach to improving adherence for adolescents living with HIV in Vietnam.
PubMed 文献 · Trials · 2019-02-28

SAAV研究采用混合方法,先在越南河内国家儿科医院对青少年HIV感染者及其照护者进行定性访谈以了解服药挑战并优化移动健康干预包,随后开展为期七个月的随机对照试验,招募80名青少年,监测一个月基线依从性后按依从性分层随机分组,比较干预组与对照组的抗逆转录病毒治疗依从性、CD4计数和HIV病毒抑制情况。

要点

  • 研究分为定性形成阶段和随机对照试验阶段,形成阶段包括40次深度访谈和8次焦点小组讨论。
  • 随机对照试验招募80名青少年,按基线依从性≥95%或<95%分层随机。
  • 干预组在漏服时触发自选提醒并接受基于依从性数据的每月咨询,对照组接受常规护理。

核心结论

  • 研究结果将为青少年HIV感染者服药依从性的障碍与促进因素、移动健康作为依从性支持工具以及影响依从性的因素提供有价值的信息。
  • 这些信息对研究人员、医务人员和政策制定者制定和实施青少年HIV感染者依从性项目有用,并可能适用于其他慢性病从青少年向成人护理过渡期间。

研究设计与样本

  • 研究采用混合方法,包括定性形成阶段和为期七个月的随机对照试验。
  • 形成阶段在越南河内国家儿科医院进行40次深度访谈(20对12-17岁青少年/照护者 dyad)和8次焦点小组讨论,另在河内门诊诊所对20名已过渡到成人护理的18-21岁青少年进行20次深度访谈。
  • 随机对照试验在国家儿科医院招募80名接受抗逆转录病毒治疗的青少年,使用无线药瓶监测一个月基线依从性,然后按最佳(≥95%按时服药)与次佳(<95%按时服药)基线依从性分层随机分组。

关键数值与推荐

  • 干预组参与者将收到自选提醒(手机短信/电话或药瓶闪光/警报),在漏服时触发,并接受基于其依从性数据的每月咨询。
  • 对照组参与者接受常规护理,并在每月常规门诊随访时获得咨询提议。
  • 六個月后比较两组的抗逆转录病毒治疗依从性、CD4计数和HIV病毒抑制,以及干预的可接受性和可行性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The overall goal of the Supporting Adolescent Adherence in Vietnam (SAAV) study is to improve understanding of an adherence feedback mHealth intervention designed to help adolescents living with HIV (ALHIV) maintain high adherence to antiretroviral therapy (ART), critical to effective treatment. Specifically, we aim to: (1) conduct formative research with Vietnamese ALHIV and their caregivers to better understand adherence challenges and refine the personalized mHealth intervention package; and (2) assess the feasibility, acceptability, and efficacy of the intervention to improve ART adherence by implementing a randomized controlled trial (RCT). METHODS: The study will utilize mixed methods. The formative phase will include 40 in-depth interviews (IDIs) with 20 adolescent (12-17 years)/caregiver dyads and eight focus group discussions with adolescents, caregivers, and clinicians at the National Hospital for Pediatrics (NHP) in Hanoi, Vietnam. We will also conduct 20 IDIs with older adolescents (18-21 years) who have transitioned to adult care at outpatient clinics in Hanoi. We will then implement a seven-month RCT at NHP. We will recruit 80 adolescents on ART, monitor their adherence for one month to establish baseline adherence using a wireless pill container (WPC), and then randomize participants to intervention versus control within optimal (≥ 95% on-time doses) versus suboptimal (< 95% on-time doses) baseline adherence strata. Intervention participants will receive a reminder of their choice (cellphone text message/call or bottle-based flash/alarm), triggered when they miss a dose, and engage in monthly counseling informed by their adherence data. Comparison participants will receive usual care and offer of counseling at routine monthly clinic visits. After six months, we will compare ART adherence, CD4 count, and HIV viral suppression between arms, in addition to acceptability and feasibility of the intervention. DISCUSSION: Findings will contribute valuable information on perceived barriers and facilitators affecting adolescents' ART adherence, mHealth approaches as adherence support tools for ALHIV, and factors affecting adolescents' ART adherence. This information will be useful to researchers, medical personnel, and policy-makers as they develop and implement adherence programs for ALHIV, with potential relevance to other chronic diseases during transition from adolescent to adult care. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03031197 . Registered on 21 January 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. DeSilva M, Vu CN, Bonawitz R, et al. The Supporting Adolescent Adherence in Vietnam (SAAV) study: study protocol for a randomized controlled trial assessing an mHealth approach to improving adherence for adolescents living with HIV in Vietnam. Trials. 2019. PMID: 30819228. doi:10.1186/s13063-019-3239-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。